A press release has been issued by Wave Life Sciences Ltd.
- Business
Announcement Date: June 25, 2024 (U.S. Time)
detail: From our key investment company, Wave, WVE-003（ Huntington's disease) Phase 1b/2a SELECT-HD Regarding test results a press release has been issued. For details, Here please refer to the original press release.